Skip to Content
Merck
CN
  • Protective effect of gastrin-releasing peptide receptor antagonist in carrageenan-induced pleural inflammation in rats.

Protective effect of gastrin-releasing peptide receptor antagonist in carrageenan-induced pleural inflammation in rats.

Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2010-04-07)
Fabricia Petronilho, Bruna de Souza, Francieli Vuolo, César A F Benetton, Emilio L Streck, Rafael Roesler, Gilberto Schwartsmann, Felipe Dal-Pizzol
ABSTRACT

We report the effects of the gastrin-releasing peptide (GRP) receptor antagonist RC-3095 in an acute inflammation model induced by carrageenan. Male Wistar rats received saline or saline containing 2% lambda-carrageenan into the pleural cavity, with some also receiving RC-3095 3 mg/kg subcutaneously, immediately after surgery. Four hours later, the rats were killed and pleural exudate was obtained for evaluation of total cell count, lactate dehydrogenase activity, total protein, cytokines analysis and nitrite/nitrate concentrations; myeloperoxidase (MPO) activity and oxidative stress were evaluated in the lung. RC-3095 exhibited pronounced anti-inflammatory actions by inhibition of leukocyte influx and blockade of MPO, nitrite/nitrate and cytokine levels. Moreover, the results showed that RC-3095 elicits action against oxidative damage in lipids and proteins, as well as increasing cell viability. The present findings suggest that GRP plays a role in acute inflammation that can be related with the reduction of oxidative damage and that it could be effective in therapeutic applications.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
RC-3095, ≥95% (HPLC), lyophilized powder